Anti-Infective Agents Market (By Type: Antibacterials [Cephalosporins, Penicillin, Fluoroquinolones, Macrolides, Carbapenem, Others], Antivirals [Azoles, Echinocandins, Polyenes, Others], Antifungals; By Route of Administration: Topical, Oral, IV, Others; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 160


The global anti-infective agents market size estimated at nearly USD 144.9 billion by 2026. The global anti-infective agents market is likely to expand at a CAGR of more than 3.6% from 2018 to 2026.

Market Dynamics:

The rising predominance of irresistible illnesses, for example, HIV, H1N1, and Ebola infection mirror the significant changes in standards of conduct of networks over the ongoing decades. The societal changes and expanding mindfulness among medicinal services experts and patients are driving the growth. Broad R&D endeavors relating to the advancement of new medications with high viability and intensity against multi-sedate safe miniaturized scale living beings is one of the main considerations invigorating the growth.

For example, in 2016, the Food and Drug Administration (FDA) affirmed drugs, for example, Discovery by Gilead, for the treatment of HIV-1 contamination and Zephier by Merck that objectives constant Hepatitis C infection (HCV) genotypes 1 or 4 diseases in grown-ups.

Associations, for example, the World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) are effectively engaged with spreading mindfulness among individuals in regards to the lethal ramifications of irresistible illnesses and the significance of early treatment. The CDC has teamed up with the National Health Ministry (NHM) trying to spread mindfulness and to upgrade the treatment of transferable illnesses in creating nations, for example, Brazil, China, Nigeria, and India.

Nevertheless, the presentation of novel therapeutics with expanded strength and viability and the commercialization of pipeline items, for example, commercialization of Omadacycline in 2018 for the treatment of Community-Acquired Bacterial Pneumonia (CABP), are required to drive the growth of the anti-infective agents market. Most organizations are growing their item portfolios by concentrating on undiscovered chances. For example, Gilead propelled Sovaldi, the main ever oral prescription for the treatment of HCV genotype 2 and 3 out of 2013.

Market Insights:

Antiviral was evaluated to be the biggest portion with a market offer of 48.8% in 2018 inferable from the high cost related with the new intense anti-viral medications, for example, Vicriviroc for the treatment of HIV. The antibacterial portion is anticipated to enroll the quickest CAGR of 4.0% during the conjecture time frame, as antibacterial is the principal line of treatment for a vast scope of diseases. Expanded medicine and availability of antibacterial due to their over-the-counter status is anticipated to additionally drive the fragment.

Advancement of blend medications to treat and forestall genuine and hazardous diseases is relied upon to push the utilization of anti-infective medications. For example, in 2012, Gilead Sciences, Inc. propelled Stribild, a far-reaching treatment routine comprehensive of four medications (cobicistat, elvitegravir, emtricitabine, and tenofovirdisoproxilfumarate) utilized for the treatment of HIV patients without earlier retroviral treatment record.

The oral course of the organization was assessed to be the biggest portion in 2018 attributable to new item improvement and the nearness of solid item pipeline. Medical clinic drug store drove the anti-infective agents market in 2018 while the web-based business is relied upon to be the quickest developing fragment during the figure time frame. Viable illness the executives includes a scope of long haul methodologies, for example, new item advancement, mergers and acquisitions, co-improvement, and business extensions. For example, in 2015, ReViral got financing of USD 21 million for the improvement of its RV521 sedate by the Wellcome Trust.

Market Segmentation:

Market Segmentation by Type:

  • Antibacterials
    • Cephalosporins
    • Penicillin
    • Fluoroquinolones
    • Macrolides
    • Carbapenem
    • Others
  • Antivirals
    • Azoles
    • Echinocandins
    • Polyenes
    • Others
  • Antifungals

Market Segmentation by Route of Administration:

  • Topical
  • Oral
  • IV
  • Others

Market Segmentation by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Specialty Pharmacies
  • E-Commerce
  • Others

Market Segmentation by Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Regional Insights:

North America market was one of the main local markets regarding income in 2018. High pervasiveness of irresistible maladies incorporating clinic obtained contaminations in both, kids and grown-ups, and the resultant abuse of antibiotics combined with expanded availability of non-solution anti-infectives are the real drivers. The Asia Pacific is one of the quickest developing territorial market attributable to the nearness of high, neglected interest for novel medications, fast upgrades in medicinal services foundation combined with bringing issues to light among social insurance experts and patients.

Market Participants:

Major companies contributing the global anti-infective agents market are Abbott Laboratories, Astellas Pharma Inc., Bayer AG, Bristol-Myers Squibb Company, Gilead Sciences, Inc., GlaxoSmithKline plc., Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Pfizer, Inc., and Sanofi.

Related Reports

Behavioral Health Market (By Disorder: Alcohol Use Disorders, Schizophrenia, Bipolar Disorder, Depression, Anxiety, Post-traumatic Stress Disorder, Substance Abuse Disorders, Eating Disorders, Others; By Service: Emergency Mental Health Services, Outpatient Counselling, Home-based Treatment Services, Inpatient Hospital Treatment Services, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Behavioral Health market is forecasted to grow at striking CAGR around 2.5 % over the forecast time frame and reach around US$ 240 billion by 2026. Behavioural health involves non-pharmacological therapies for circumstances like mental health, drug abuse disorder, etc. Due to mental illnesses,

Transcranial Magnetic Stimulator Market (By Type: dTMS, rTMS, Others; By Application: Depression, Epilepsy) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026Transcranial Magnetic Stimulator Market (By Type: dTMS, rTMS, Others; By Application: Depression, Epilepsy) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global transcranial magnetic stimulator market size is accounted over USD 2.1 Billion by 2026 and growing at CAGR 9.0% during the forecast period 2019-2026. Transcranial magnetic stimulators are widely used in the treatment of brain and neurological diseases. The transcranial magnetic stimulators is a non-invasive technique which applies magnetic pulses to the brain that uses magnetic field to reduce chronic pain and stimu

Sacral Nerve Stimulation Market (By Product: Implantable, External; By Application: Urinary & Fecal Incontinence, Urge Incontinence, Chronic Anal Fissure, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global sacral nerve stimulation market size is expected to reach over 2.3 USD billion by 2026 at the CAGR 12.1% during the forecast period, 2019-2026. A Sacral nerve stimulation is implanted as a device to control bladder functions by delivering controlled electrical impulses to the sacral nerves that modulate the neural pathways. It is an effective and safe treatment for patients suffering fro

Medical Imaging Workstations Market (By Modality: Computed Tomography, MRI, X-ray; By Component: Visualization Software, Display Units; By Usage Mode: Thin, Thick; By Application: Diagnostic Imaging, Clinical Review; By End User: Hospital and Clinics, Diagnostics Centers, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global market for Medical Imaging Workstations is estimated to grow at a significant rate of 8.5% during the forecasted period and is expected to reach over 2.3 billion by 2026. Medical imaging workstations are used in the hospitals while setting up the equipments. During last few years there is an significant increase in the prevalence of the various diseases and accidents which has increased

Laser Hair Removal Market (End User: Dermatology Clinics, Beauty Clinics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global laser hair removal market value is accounted over USD 3.9 Billion by 2026 and is expected to grow at CAGR 15.4% during the forecast period 2019-2026. The global laser hair removal product market is driven by increased awareness regarding personal appearance and rising health awareness among the population. Additionally, improved standard of living and rising disposable income tremendously affects the laser hair remo

Idiopathic Pulmonary Fibrosis Treatment Market (By Drug Class: Tyrosine Inhibitors, MAPK Inhibitors, Autotaxin Inhibitors; By End User: Hospitals, Long-term Care Facilities, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global Idiopathic Pulmonary Fibrosis Treatment Market is expected to reach over 4.2 USD billion by 2026 and growing at CAGR 11.6% during the forecast period 2019-2026. During last few years, there is a significant increase in the number of respiratory related diseases. Increasing prevalence of the various respiratory diseases, rising geriatric population across the globe, and increasing awareness about health have driven t

Cart Summary